Infectious Diseases and HIV Conference

Pharmacology and therapeutics play a crucial role in the management of infectious diseases. Management of this wide category of diseases is made by selection and the use of medication to optimize patient outcome.

In this session, you will receive comprehensive information about the principles of pharmacology, the therapeutic applications, and the innovations for treating infectious diseases. This session will introduce pharmacology and, therefore, the core information related to drug ADME. Being aware of these principles helps professionals make good decisions with regard to the selection and dosing of drugs, as well as possible drug interactions.

Participants will also be introduced to the pharmacodynamics of various antimicrobial agents, such as antibiotics, antivirals, antifungals, and antiparasitics. Therapeutics is the practical application of pharmacological principles to a clinical setting. This workshop will review some of the evidence-based approaches to the selection of appropriate therapies for a variety of infectious diseases and how pathogen susceptibility, patient characteristics, and the intensity of infection influence such considerations.

Case studies will be used to illustrate how infection management is quite challenging among a number of different patient populations, including pediatrics and geriatrics, as well as immunocompromised patients. Pharmacologists and therapeutics experts will present emerging trends: New drug development; Combination therapy; Targeted therapy.

The role of pharmacogenomics in tailoring treatment regimens to individual patients and enhancement of efficacy and safety of therapies would be understood. Another critical issue, the session will broach, is that of antimicrobial resistance, through a call for innovative approaches to drug development as well as stewardship programs to optimize antibiotic use.

This includes discussion of very current research and developments relating to new classes of antimicrobials and alternative therapies such as monoclonal antibodies and phage therapy.

We can move toward more effective pharmacological and therapeutic strategies in the management of infectious diseases by establishing opportunities for collaboration between healthcare providers, researchers, and policymakers.

Join us for an exciting session with leading experts as we learn through the intricacies of pharmacology and therapeutics with regards to improving our understanding and management of infections.